CA2067724C - Dispositif jetable pour diagnostic - Google Patents
Dispositif jetable pour diagnostic Download PDFInfo
- Publication number
- CA2067724C CA2067724C CA002067724A CA2067724A CA2067724C CA 2067724 C CA2067724 C CA 2067724C CA 002067724 A CA002067724 A CA 002067724A CA 2067724 A CA2067724 A CA 2067724A CA 2067724 C CA2067724 C CA 2067724C
- Authority
- CA
- Canada
- Prior art keywords
- testing system
- well
- diagnostic testing
- diagnostic
- cupped
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 claims abstract description 68
- 238000002405 diagnostic procedure Methods 0.000 claims abstract description 50
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 41
- 239000012491 analyte Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 230000000984 immunochemical effect Effects 0.000 claims description 2
- 230000008054 signal transmission Effects 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 2
- 238000006911 enzymatic reaction Methods 0.000 claims 1
- 229920001169 thermoplastic Polymers 0.000 claims 1
- 239000012815 thermoplastic material Substances 0.000 claims 1
- 239000004416 thermosoftening plastic Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 6
- 238000012800 visualization Methods 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 238000003475 lamination Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000003856 thermoforming Methods 0.000 description 2
- 241001552669 Adonis annua Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000032765 Device extrusion Diseases 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002067724A CA2067724C (fr) | 1992-04-30 | 1992-04-30 | Dispositif jetable pour diagnostic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002067724A CA2067724C (fr) | 1992-04-30 | 1992-04-30 | Dispositif jetable pour diagnostic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2067724A1 CA2067724A1 (fr) | 1993-10-31 |
| CA2067724C true CA2067724C (fr) | 2001-01-02 |
Family
ID=4149750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002067724A Expired - Fee Related CA2067724C (fr) | 1992-04-30 | 1992-04-30 | Dispositif jetable pour diagnostic |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2067724C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111879591A (zh) * | 2020-09-01 | 2020-11-03 | 中科嘉睿(天津)医疗科技发展有限公司 | 一种干化学标准试剂片及其制备方法 |
-
1992
- 1992-04-30 CA CA002067724A patent/CA2067724C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2067724A1 (fr) | 1993-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0512059B1 (fr) | Systeme de diagnostic jetable | |
| AU2008318717B2 (en) | Method and apparatus for coding diagnostic meters | |
| AU712523B2 (en) | Analyte concentration measurement using a hollow frustum | |
| CA1206078A (fr) | Reactifs auto-empilables | |
| EP0779983B1 (fr) | Bandelette de detection d'analyte a lecture optique et a repere d'orientation situe sur la bandelette | |
| EP0128422A2 (fr) | Support pour bandes-test | |
| CA2212476A1 (fr) | Appareil de mesure de dosage a distance de la concentration d'un analyte | |
| WO1996007893A1 (fr) | Bandelette a reperage de position pour la detection d'analytes | |
| CA2427083A1 (fr) | Dispositifs et methodes de determination de la concentration d'une substance a analyser | |
| CA2067724C (fr) | Dispositif jetable pour diagnostic | |
| US20130164190A1 (en) | Sample Collection System with Integrated Drug Testing Apparatus | |
| US6010663A (en) | Die cut reagent membrane, holder | |
| US6418606B1 (en) | Method of manufacturing an assaying device | |
| US20030232451A1 (en) | Device for the testing of fluid samples and process for making the device | |
| US20070059678A1 (en) | Breast milk contaminant detection device | |
| EP1298437A1 (fr) | Dispositif d'essai colorimétrique avec taux d'erreur réduit | |
| US11559810B2 (en) | Method and apparatus for coding diagnostic meters | |
| US20070041867A1 (en) | Urinary Diagnosis process | |
| HK1057397A (en) | Device and method for analyte concentration determination | |
| Forest et al. | Evaluation of the automatic analyser hitachi 705 | |
| HK1051571B (en) | Colorimetric test device with reduced error |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed | ||
| MKLA | Lapsed |
Effective date: 20040430 |